2020 NCATS ASPIRE Reduction-to-Practice Challenge Winners, Stage 2, Milestone 1*
Contact
NCATS is happy to announce the winners of the 2020 NCATS ASPIRE Reduction-to-Practice Challenge, Stage 2, Milestone 1: Prototype Development and Milestones Delivery.
See details about the ASPIRE 2020 Challenge.
*According to the rules for these ASPIRE Design Challenges, non-U.S. citizens and non-permanent residents were not eligible to win a monetary prize (in whole or in part).
- Iterative Learning and Automated Modular Platform for Optimum Nonaddictive Analgesic Discovery
- Closed Loop Bio-Assay-Chemputer for Next Generation Analgesics (BioChemputer)
- Development of a Comprehensive Integrated Platform for Translational Innovation in Pain, Opioid Abuse Disorder and Overdose
- Accelerating Molecular Innovation in Pain through an AI-Driven, Human-Guided and Automated Open Drug Discovery Platform
Iterative Learning and Automated Modular Platform for Optimum Nonaddictive Analgesic Discovery
Gaurav Chopra
Ram Samudrala
R. Graham Cooks
Connor W. Coley
Panayotis K. Thanos
Jun-Xu Li
Purdue University
State University of New York (SUNY)
Purdue University
Massachusetts Institute of Technology
University at Buffalo
University at Buffalo
Closed Loop Bio-Assay-Chemputer for Next Generation Analgesics (BioChemputer)
Babak Esmaeli-Azad
Leroy Cronin
Sara I. Walker
Philip J. Kitson
S. Hessam M. Mehr
James Zapf
Evan Snyder
Larry H. Ellisman
Shaochen Chen
CiBots, Inc.
University of Glasgow
Arizona State University
University of Glasgow
University of Glasgow
Visionary Pharmaceuticals Inc.
Sanford Consortium for Regenerative Medicine
University of California, San Diego
University of California, San Diego
Development of a Comprehensive Integrated Platform for Translational Innovation in Pain, Opioid Abuse Disorder and Overdose
Jeffrey Skolnick
Andre Ghetti
Nicole Jung
Hongyi Zhou
Georgia Institute of Technology
ANABIOS Corporation
Karlsruhe Institute of Technology
Georgia Institute of Technology
Accelerating Molecular Innovation in Pain through an AI-Driven, Human-Guided and Automated Open Drug Discovery Platform
Daniel H. Robertson
Timothy I. Richardson
Gaurav Chopra
Richard M. van Rijn
Indiana Biosciences Research Institute
Indiana University School of Medicine
Purdue University
Indiana University School of Medicine